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ORIGINAL RESEARCH COMMUNICATION
PhenolicAU1c Acid Intake, Delivered Via Moderate Champagne
Wine Consumption, Improves Spatial Working Memory
Via the Modulation of Hippocampal and Cortical Protein
Expression/Activation
AU2c Giulia Corona,1,* David Vauzour1,*,{ Justine Hercelin,1 Claire M. Williams,2 and Jeremy P.E. Spencer1
Abstract
Aims: While much data exist for the effects of flavonoid-rich foods on spatial memory in rodents, there are no
such data for foods/beverages predominantly containing hydroxycinnamates and phenolic acids. To address
this, we investigated the effects of moderate Champagne wine intake, which is rich in these components, on
spatial memory and related mechanisms relative to the alcohol- and energy-matched controls. Results: In
contrast to the isocaloric and alcohol-matched controls, supplementation with Champagne wine (1.78ml/kg
BW, alcohol 12.5% vol.) for 6 weeks led to an improvement in spatial working memory in aged rodents.
Targeted protein arrays indicated that these behavioral effects were paralleled by the differential expression of
a number of hippocampal and cortical proteins (relative to the isocaloric control group), including those
involved in signal transduction, neuroplasticity, apoptosis, and cell cycle regulation. Western immunoblotting
confirmed the differential modulation of brain-derived neurotrophic factor, cAMP response-element-binding
protein (CREB), p38, dystrophin, 2¢,3¢-cyclic-nucleotide 3¢-phosphodiesterase, mammalian target of rapamycin
(mTOR), and Bcl-xL in response to Champagne supplementation compared to the control drink, and the
modulation of mTOR, Bcl-xL, and CREB in response to alcohol supplementation. Innovation: Our data
suggest that smaller phenolics such as gallic acid, protocatechuic acid, tyrosol, caftaric acid, and caffeic acid, in
addition to flavonoids, are capable of exerting improvements in spatial memory via the modulation in hip-
pocampal signaling and protein expression. Conclusion: Changes in spatial working memory induced by the
Champagne supplementation are linked to the effects of absorbed phenolics on cytoskeletal proteins, neu-
rotrophin expression, and the effects of alcohol on the regulation of apoptotic events in the hippocampus and
cortex. Antioxid. Redox Signal. 00, 000–000.
Introduction
Declines in both cognitive and motor performance dueto structural- and activity-related changes in neuronal
and glial function are known to occur during normal aging
(15). Recently, flavonoid-containing foods/beverages have
received much attention with regard to their neuroprotective
effects (49), including a potential to protect neurons against
neurotoxin-induced injury (39, 64), suppress neuroin-
flammation (57), and promote memory and learning (30, 42,
45, 60). In addition to this, numerous epidemiological studies
have reported that a low-to-moderate intake of wine (1–2
glasses per day), which is also rich in flavonoids, may reduce
the risk of coronary heart disease, ischemic stroke, dementia,
and cognitive impairment (25, 27, 28, 37). As such, there is an
interest in the potential of regular, moderate wine
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consumption to counteract normal brain aging and in im-
proving memory and learning, through their potential to
deliver relatively high amounts of flavonoids (8, 10). How-
ever, although redwines contain high levels of flavonoids and
other phenolics relative to white wines (32), Champagne wine
is relatively rich in phenolic compounds (65) such as hydro-
xybenzoic acids, hydroxycinnamic acids (and their tartaric-
derivative esters), phenolic alcohols, and phenolic aldehydes
(6). The increased levels of phenolics in Champagne wine
compared to other white wines derive predominantly from
the two red grapes, Pinot Noir and Pinot Meunier, which are
used in its production along with the white grape Chardon-
nay (9). As such, it is hypothesized that Champagne may
deliver significant quantities of phenolics, which may in turn
be capable of driving vascular and neuronal effects capable of
mediating changes in the cognitive performance.
Previously, Champagne wine consumption has been ob-
served to improving acute vascular function (62), in a similar
manner to that of red wine (7, 12). Further, tyrosol, caffeic
acid, and gallic acid, the phenolic compounds found at rel-
atively high concentrations in Champagne, have been
shown to potently inhibit peroxynitrite-induced cellular in-
jury at physiologically relevant concentrations (0.1 to 10lM)
(65), while nanomolar levels of tyrosol, caffeic acid, and
p-coumaric acid protect cortical neurons against 5-S-cysteinyl-
dopamine induced injury (61). Indeed, the levels of protection
induced by these phenolics were equal to that, if not greater
than, observed for a similar concentration of the flavonoids,
( + )-catechin, (- )-epicatechin, and quercetin (61). The hy-
droxycinnamate, caffeic acid, has also been shown to be
neuroprotective, counteracting inflammatory injury induced
by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by
decreasing the production of a number of inflammatory cyto-
kines, downregulating the expression of inducible nitric oxide
synthase, cyclooxygenase-2, and glial fibrillary acidic protein
and lowering the production of NO and PGE2 (56). In addition,
caffeic acid–phenethyl ester may protect cerebellar granule
neurons against glutamate-induced neuronal death via inhibi-
tion of p38 phosphorylation and caspase-3 activation (67) and
significantly prevents hypoxic ischemic-induced neonatal rat
brain damage in the cortex, hippocampus, and thalamus (68).
Despite these data, the impact of such phenolics on neu-
ronal function/activity has received little attention relative to
flavonoids, in particular in animal and human trials, and there
is a lack of understanding with regard to their mechanisms of
action in the brain in vivo. In particular, there are no data
relating to the consumption of small phenolics and hydro-
xycinnamates, such as those present in Champagne wine on
memory and neurocognitive performance. To address this,
we have investigated the potential effects of moderate, me-
dium-term Champagne wine intake on age-related deficits in
spatial working memory and motor performance and the
potential mechanisms of action in the hippocampus and
cortex.
Results
Analysis of phenolic constituents in Champagne wine
The high performance liquid chromatography (HPLC)
analysis of the phenolic extract obtained from Champagne
wine allowed us to identify and quantify themajor constituents
present ( b F1Fig. 1). The chromatographic profile of the organic
extract at 280nm (Fig. 1A) and 320nm (Fig. 1B) highlights the
major phenolic components in the Champagne extract utilized:
gallic acid (peak 1), protocatechuic acid (peak 2), tyrosol (peak
3), caftaric acid (peak 4), and caffeic acid (peak 5). Overlapping
standard runs with the flavonoids catechin (Std 6), epicatechin
(Std 7), and the stilbene resveratrol (Std 8) indicated that these
polyphenols were undetectable in the Champagne used (Fig.
1). The major phenolics identified (Fig. 1C) were quantified to
precisely characterize the intake on supplementation of the
Champagne intervention (Fig. 1D).
Food intake and animal weight. Animals were fed daily
with Champagne, an isocaloric control or an isocaloric alcohol-
containing control (Fig. 1D). There were no significant differ-
ences in food intake among the three groups throughout the
study period (isocaloric control: 20.81 g/day; alcohol control:
20.42 g/day; Champagne group: 20.36 g; p> 0.05). At baseline,
the control, alcohol, and Champagne group animals weighed
478.11 (– 18.23), 484.63 (– 48.06), and 455.15 (– 36.97) g, re-
spectively, and there was no significant weight change
throughout the intervention period in any of the groups (av-
erage weights at week 6: 480.70– 15.75, 490.80– 50.43, and
462.19– 31.20 g, respectively; p> 0.05).
Spatial working memory. At baseline, the animals per-
formed at an average choice accuracy of 4.25 (– 0.27), and there
was no significant difference in choice accuracy between the
three experimental groups ( b F2Fig. 2). At 6 weeks, there was a
reduction in the choice accuracy of the both isocaloric control
group (3.50– 0.27) and alcohol group (4.00– 0.38) and an in-
crease in the choice accuracy of the Champagne group
(5.29– 0.18). A two-way analysis of variance (ANOVA) with
repeated measures indicated that there were no significant
changes with respect to time (F(1,20)= 0.022, MSE= 0.026,
p= 0.884), or between treatments (F(2,20)= 1.863, MSE= 2.734,
p= 0.181), but there was a trend to significance with regard to
the interaction between treatment and time (F(2,20)= 2.955,
MSE= 3.536, p= 0.075). Bonferroni post-hoc analysis indicated
that this trend to significance was predominantly driven by a
significant difference in choice accuracy between the isocaloric
control group and the Champagne group at 6 weeks ( p< 0.01).
Motor performance. A two-way ANOVA with repeated
measures indicated that there was no significant affect of the
interventions on the distance covered by the animals on
Innovation
Flavonoid-rich foods and beverages have been shown
to exert a multiplicity of neuroprotective effects in the
brain, whereas little is known regarding the actions of
smaller phenolics/polyphenols. Our data provide the first
evidence that phenolics such as gallic acid, protocatechuic
acid, tyrosol, caftaric acid, and caffeic acid, delivered via
moderate Champagne wine intake, also induce im-
provements in spatial memory in aged rodents and are
dependent on the potential of these phenolics to modu-
late the expression of a number of proteins in the cortex
and hippocampus related to the control of cell signaling,
neuronal plasticity, cell cycle, and apoptosis.
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beam-walking tests (time: F(1,19) = 1.101, MSE = 0.621,
p = 0.307; treatment: F(2,19) = 0.855, MSE = 4.058, p= 0.441; in-
teraction: F(2,19) = 1.080, MSE = 0.609, p= 0.360) (Fig. 2A). Si-
milarly, the latency time (Fig. 2B) was not significantly
affected by the control or Champagne intervention for 6
weeks (time: F(1,19) = 1.703, MSE= 33.783, p= 0.208; treatment:
F(2,19) = 0.441, MSE= 36.414, p= 0.650; interaction:
F(2,19) = 0.293, MSE= 5.814, p = 0.749). In agreement with this,
there were no significant effects of any of the treatments on
calculated walking speed (Fig. 2C; time: F(1,19) = 1.742, MSE =
41.637, p = 0.203; treatments (F(2,19) = 1.155, MSE= 52.296,
p= 0.336; interaction: F(2,19) = 0.690, MSE = 16.500, p= 0.514).
These data suggest that neither alcohol nor Champagne in-
tervention had an influence on motor performance.
Protein expression array. Forty hippocampal ( b F4Fig. 4) and
31 cortical ( b F5Fig. 5) proteins related to signal transduction,
neuroplasticity, apoptosis, and cell cycle regulation were
FIG. 1. Major constituents of
the control and test interven-
tions. Chromatographic sepa-
ration of the aqueous/organic
extract of Champagne wine at
(A) 280 nm and (B) 320 nm, in-
dicating quantified phenolics in
the extract (1 to 5), and stan-
dards of epicatechin (Std 6),
catechin (Std 7), and resveratrol
(Std 8) to mark their potential
retention time. (C) Structures of
major phenolic compounds
present: 1: gallic acid; 2: proto-
catechuic acid; 3: tyrosol; 4:
caftaric acid; 5: caffeic acid.
(D) Quantification of phenolic
compounds and of other major
constituents of the control and
test interventions.
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significantly modulated ( p< 0.05) after 6 weeks of Cham-
pagne intake relative to the isocaloric control. In both the
hippocampus and cortex, Champagne intervention modu-
lated a range of proteins involved in the mitogen-activated
protein kinase (MAPK) signaling and the epidermal growth
factor receptor signaling cascade, such as p38 and phospho-
Raf. In addition, in the cortex, Champagne downregulated the
expression of some calcium-activated protein kinases (PKC a,
PKC b, and PKC g) and phospholipases C and A2. Cham-
pagne intervention increased the expression of the myelin-
associated enzyme 2¢,3¢-cyclic-nucleotide 3¢-phosphodiesterase
(CNPase) in the hippocampus, and a range of neuroplasticity-
related proteins in both the hippocampus and cortex (dys-
trophin, plakoglobin,AU3c tryptophane hydroxylase, and spectrin),
whereas it downregulated NGFR p75 and NMDAR-2a re-
ceptors in the cortex only. Finally, Champagne supplemen-
tation also led to the modulation of apoptotic proteins (i.e.,
caspases and Bcl family proteins) and cell cycle/nuclear pro-
teins, including those of the antiapoptotic proteins Bcl-xL and
Bcl-x, and cyclin A and Cdc27 in both the hippocampus and
cortex. Probe protein array analysis provided several new
candidate proteins that were selected based on the expression
levels and role in neuronal plasticity (p38, CNPase, dystro-
phin, and Bcl-xL), along with the previously identified pro-
teins brain-derived neurotrophic factor (BDNF), pro-BDNF,
cAMP response-element-binding protein (CREB), mamma-
lian target of rapamycin (mTOR), Erk, JNK, Akt, Arc, and
PKA C-a absent in the array, for further evaluation and/or
confirmation by western immunoblotting. A complete list of
the proteins analyzed with the protein array is presented as a
supplementary material (SF1c Supplementary Fig. S1: hippocam-
pus, and
SF2c
Supplementary Fig. S2:AU4c cortex; Supplementary Data
are available online at www.liebertpub.com/ars).
Immunoblotting. In comparison to the isocaloric and al-
cohol control interventions, Champagne intervention led to
significant increases in the hippocampal levels of phospho-
p38, pCREB (Ser133) and BDNF ( p< 0.001; p< 0.05; and
p < 0.001, respectively) ( b F6Fig. 6A). In addition, there was a
significant positive correlation between the hippocampal
BDNF levels in individual animal performance on spatial
memory tasks (R = 0.613, p < 0.01) (Fig. 6B) and between the
hippocampal phospho-p38 levels and spatial performance
(R= 0.681, p< 0.01). Similarly, Champagne intervention led to
the increased expression of dystrophin and CNPase ( p < 0.05
and p< 0.01, respectively) ( b F7Fig. 7), with a significant positive
correlation existing between spatial memory task perfor-
mance and hippocampal levels of dystrophin (R = 0.74,
p < 0.05) and CNPase (R= 0.529, p< 0.05).
In contrast, mTOR phosphorylation and Bcl-xL were al-
tered by both the Champagne and alcohol treatments ( b F8Fig. 8).
Hippocampal levels of Bcl-xL were found to be significantly
reduced in animals supplemented with both Champagne
( p< 0.001) and alcohol ( p< 0.01) compared to the control,
although to a greater extent in the Champagne group
( p< 0.001). mTOR activation on the other hand was signifi-
cantly higher in both the Champagne- ( p< 0.001) and alcohol-
supplemented animals ( p< 0.05) compared to the isocaloric
FIG. 2. Effect of Champagne supplementation on rat’s
spatial memory performance measured as choice accuracy
(number of correct choices) in a T-maze alternation task.
Maximum score is 8 correct choices. Results are presented as
means – SEM (n = 8). Two-way ANOVA indicated a trend to
significance on the interaction between treatment and time
(F3.536 = 2.955, p= 0.075), and Bonferroni post hoc test indi-
cated a significant effect of Champagne vs control at 6 weeks
(b = p < 0.01). ANOVA, analysis of variance.
FIG. 3. Effect of Champagne supplementation on rat’s
motor skills (stationary-beam scores) in Champagne-sup-
plemented animals. (A) Distance. (B) Latency time. (C)
Walking speed. Results are presented as means – SEM (n = 8).
No significant differences were found (two-way ANOVA). bAU7
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control. Champagne-induced hippocampal changes in the
p38, CNPase, dystrophin, and Bcl-xL levels in the hippo-
campus were in agreement with those observed using anti-
body arrays (Fig. 4). There were no significant alterations in
the activation state, or expression of, Akt, Arc, Erk, JNK, PKA
C-a, and pro-BDNF in the hippocampus in response to either
alcohol or Champagne intervention (T1c Table 1).
With regard to protein expression in the cortex, the effect on
mTOR was opposite to that observed in the hippocampus,
with both alcohol ( p < 0.001) and Champagne ( p < 0.001) in-
tervention leading to significant reductions in mTOR levels
relative to the isocaloric control (F9c Fig. 9). However, in a similar
manner to that observed in the hippocampus, both alcohol
and Champagne evoked significant increases in cortical
phospho-CREB ( p < 0.05). There were no significant alter-
ations in the activation state, or expression of, Akt, Arc, Bcl-
xL, BDNF, CNPase, Erk, JNK, p38, and pro-BDNF in the
cortex (Table 1).
Discussion
Human clinical trials and animal studies have identified
flavonoid-rich foods and beverages as being capable of de-
laying the onset of age-related cognitive impairment (20, 21,
41, 48, 49, 63, 69). Flavonoids present in such foods have been
postulated to evoke protection against cognitive aging
through the actions of absorbed flavonoids and their metab-
olites on neurons and glia, enhancing the existing neuronal
function and/or to stimulating neuronal regeneration (20,
26, 49, 63). Although antioxidant mechanisms cannot be
excluded (70), recent datasets suggest that such effects are
mediated by their ability to modulate neuronal signaling (48,
50, 52), stimulate neurotransmitter release (22), increase ce-
rebrovascular blood flow (14), and even stimulate hippo-
campal neurogenesis (5). Although a large body of evidence
has accumulated for flavonoid-rich foods (26), there is less
known regarding the influence of nonflavonoid phenolics on
similar behavioral and molecular parameters. In the current
study, we show that Champagne wine, which is rich in
phenolics, such as gallic acid, protocatechuic acid, tyrosol,
caftaric acid and caffeic acid, but essentially lacking in fla-
vonoids, is also capable of enhancing spatial working
memory (without altering motor performance) in aged ani-
mals. In contrast, moderate alcohol intake failed to induce
spatial memory changes. These observations are in agree-
ment with those observed following long-term red wine in-
take in a similar model of hippocampal-dependent spatial
memory (2).
FIG. 4. Differentially ex-
pressed proteins (antibody
array) in the hippocampus
between the Champagne- and
control-treated animals. Re-
sults are presented as mean
log2-ratios – SD (n = 4). All
changes were statistically sig-
nificant ( p< 0.05).
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The effects of Champagne on spatial memory were paral-
leled by a number of changes in the hippocampal and cortical
protein expression, which may underpin the performance on
spatial memory tasks. Perhaps, most notably, dystrophin and
CNPase were modulated by Champagne supplementation,
but not alcohol. CNPase (2¢,3¢-cyclic nucleotide 3¢-phos
phosphodiesterase) is a myelin-associated enzyme that con-
stitutes around 4% of total central nervous system myelin
protein, and is thought to undergo significant age-associated
changes (17), and is reduced in Alzheimer’s disease and
Down’s syndrome patients (66). Further, Champagne-
induced hippocampal increases in the cytoskeletal associated
protein, dystrophin, may be beneficial, as a lack of this protein
in the hippocampus has been associated with impaired cog-
nitive function (35), spatial memory (59), and long-term po-
tentiation (58). Indeed, patients lacking dystrophin in the
hippocampus and neocortex (due to mutation in the dystro-
phin gene) display a range of cognitive deficits (1). Interven-
tion with the phenolic-rich Champagne also led to the
increased expression of a range of other cytoskeletal proteins,
including plakoglobin (c-catenin), spectrin, calponin, cyto-
keratin pep4 and pep19,myosin Va, and focal adhesion kinase
(FAK). Such proteins facilitate complex neuronal network
formation in the brain and operate with neuronal membrane
proteins (e.g., ion channels, scaffolding proteins, and adaptor
proteins) at the sites of synaptic contacts to regulate sy-
naptogenesis and coordinate synaptic strength (16, 38).
BDNF, a major regulator of synaptic transmission and
plasticity at adult synapses (31), has previously been shown to
partly mediate flavonoid-induced improvement in spatial
memory through the ERK/Akt-CREB-BDNF pathway (42,
69). We show that phenolics present in Champagne also
FIG. 5. Differentially ex-
pressed proteins (antibody
array) in the cortex between
the Champagne- and con-
trol-treated animals. Results
are presented as mean log2-
ratios – SD (n = 4). All chan-
ges were statistically signif-
icant ( p< 0.05).
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increase the BDNF andCREB levels in the hippocampus and a
number of other neuroplastic proteins, notably dystrophin,
plakoglobin, tryptophane hydroxylase, and CNPase. CREB is
well known to be involved in memory and learning processes
(53), via its selective activation of numerous downstream
genes, including BDNF (3), and the CREB/BDNF pathway
plays a critical role in synaptic plasticity and memory con-
solidation (34). In contrast to previous findings with flavo-
noid-rich interventions, we observed no significant
modulation of ERK1/2 or Akt by Champagne intervention,
suggesting that BDNF is not regulated in this manner. Rather,
phenolic-induced BDNF expression may be regulated
through p38 signaling in the hippocampus, leading to a de-
crease in the ERK/p38 activity ratio and the direct inhibition
of raf-1 by p38 (18). Indeed, raf-1 was significantly down-
regulated by Champagne intervention, together with a
number of other proteins connected to raf-1 in the hippo-
campus (p38, ATF2, GADD 153, p57kip2, Cdc27, Cyclin A,
E2F1, PCAF, c-myc, GRB2, FAK, and spectrin) and in the
cortex (p38, Cyclin A, Cyclin D1, c-myc, caspase 7, NGRF p75,
PTEN, phospholipase C g1 and A2 group V, PKC a, b, and g,
NMDAR 2a, Pyk2, and Tau), as indicated by STRING
FIG. 6. Immunoblotting
analysis of proteins extrac-
ted from the hippocampus.
(A) Crude lysates (20–40 lg
protein) were immuno-
blotted with antibodies that
specifically recognize phos-
pho-p38, total-p38, phos-
pho-CREB, total-CREB, BDNF,
and GAPDH. Results (phos-
pho-/total ratio for p38 and
CREB; protein/GAPDH ratio
for BDNF) are presented as
means – SEM (n ‡ 6). a= p<
0.001; c= p< 0.05 represent
significant differences vs con-
trol (one-way ANOVA). (B)
Correlation between choice
accuracy in spatial memory
task and hippocampal BDNF
protein levels, after 6 weeks
of dietary interventions, (n=
19; r= 0.613; p< 0.01). BDNF,
brain-derived neurotrophic
factor; CREB, cAMP response-
element-binding protein.
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functional protein association networks (19). Further, the ob-
served increases in p38 activation are in agreement with
previous findings, showing that p38 activity may mediate
BDNF synthesis in the rat hippocampus (23).
Further, unlike flavonoids, Champagne phenolics did not
specifically regulate Akt-mTOR signaling, although alcohol
treatment did appear to increase in the activation status of
mTOR, a protein that regulates survival, differentiation, and
development of neurons and is crucial for synaptic plasticity,
learning, and memory formation in the adult brain (54),
something which agrees with previous datasets (29). Simi-
larly, reductions in the hippocampal levels of Bcl-xL levels
were reduced by both Champagne and alcohol, suggesting
that alcohol intake itself may play a role in apoptotic regula-
tion in the brain (13). A number of other apoptotic proteins
were found to be significantly downregulated by Champagne
in the hippocampus (Bcl-xL, Bcl-x, caspases 5, 6, and 11, PSR,
and GADD 153) and in the cortex (Bcl-xL, Bcl-x, Bcl-10, and
caspases 7 and 11), although it is unclear whether alcohol
alone would also mediate similar reductions. Antiapoptotic
proteins such as Bcl-xL and other members of the Bcl-2 family
have been implicated in the selective neuronal loss observed
in AD (47) and have been found to be upregulated in the
Alzheimer brains (24).
In summary, the potential of Champagne to beneficially
influence spatial memory appears to bemediated by its ability
to induce a number of changes in hippocampal and cortical
protein expression, which occur in parallel to behavioral ef-
fects. Such effects on protein expression may result via the
direct actions of individual phenolics such as tyrosol, caffeic
acid, and their metabolites on hippocampal and cortical
neurons/glia after their uptake into the brain, or via the syn-
ergistic effects of these phenolics along with other Cham-
pagne wine components. Although we did not observe this
directly, previous data support the potential for such pheno-
lics to undergo transfer across the blood–brain barrier (BBB)
(11, 44). While the ability of flavonoids to cross the BBB is
believed to be dependent on lipophilicity, small phenolics
may transverse the BBB via amino acid transporters, such as
have been reported for 4-ethylcatechol (33). Further, caffeic
acid shares structural similarities with l-3,4-dihydrox-
yphenylalanine and, as such, may undergo BBB transport via
catecholamine transporter systems. Together, our data indi-
cate that moderate Champagne intake and phenolic acid in-
take in general may be beneficial in counteracting memory
impairments associated with aging, a finding that broadly
supports human epidemiological data (25, 27, 28, 37). Ques-
tions remain as to whether such an intervention would have a
similar efficacy in younger animals, and how this compares to
FIG. 7. Immunoblotting analysis of proteins extracted
from the hippocampus. Crude lysates (20–40 lg protein)
were immunoblotted with antibodies that specifically rec-
ognize dystrophin, CNPase, and GAPDH. Results (protein/
GAPDH ratios) are presented as means – SEM (n‡ 6).
b= p< 0.01; and c= p< 0.05 represent significant differences vs
control (one-way ANOVA). CNPase, 2¢,3¢-cyclic-nucleotide
3¢-phosphodiesterase.
FIG. 8. Immunoblotting analy-
sis of proteins extracted from
hippocampus. Crude lysates
(20–40 lg protein) were im-
munoblotted with antibodies that
specifically recognize phospho-
mTOR, total-mTOR, Bcl-xL, and
GAPDH. Results (phospho-/total
ratio for mTOR; protein/GAPDH
ratio for Bcl-xL) are presented as
means – SEM (n‡ 3). a= p< 0.001;
b = p< 0.01; and c = p < 0.05 repre-
sent significant differences vs
control; a= p< 0.001 represent sig-
nificant differences versus alco-
hol (one-way ANOVA). mTOR,
mammalian target of rapamycin.
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our observations in old animals. However, phase-I and II
metabolic differences that occur with age may influence the
circulating levels of phenolics and their metabolites, and thus
spatial memory improvements may also be influenced.
Materials and Methods
Materials
Gallic acid, protocatechuic acid, caffeic acid, Bradford re-
agent, panorama antibody array Cell Signaling Kit, CelLytic
MT Cell Lysis Reagent, and HRP-conjugated goat anti-rabbit
and anti-mouse secondary antibodies were obtained from
Sigma. Caftaric acid was obtained from Apin Chemicals.
Tyrosol was purchased from Extrasynthese. PhosSTOP
phosphatase inhibitors and Complete Miniprotease inhibitors
were obtained from Roche. Precision Plus Protein Western C
Standards and Precision Protein StrepTactin–HRP conjugate
were purchased from Biorad. Primary antibodies used were
anti-BDNF (1:200) and anti-pro-BDNF (1:200) from Millipore;
anti-phospho-p38 Thr180/Tyr182 (1:1000), anti-total-p38
(1:1000), anti-phospho-CREB Ser133 (1:1000), anti-total-CREB
(1:1000), anti-phospho-Erk1/2 Thr202/Tyr204 (1:2000), anti-
total-Erk1/2 (1:2000), anti-phospho-Akt Ser473 (1:1000), anti-
total-Akt (1:1000), anti-phospho-JNK Thr183/Tyr185
Table 1. Immunoblotting Analysis of Proteins Extracted from the Hippocampus and Cortex
Control Champagne Alcohol
Mean SEM Mean SEM Mean SEM
Hippocampus
Akt ph/tot 0.581 0.023 0.535 0.009 0.543 0.004
Arc/GAPDH 0.722 0.130 0.684 0.214 0.803 0.059
Erk1 ph/tot 0.271 0.009 0.260 0.016 0.248 0.019
Erk2 ph/tot 0.116 0.003 0.120 0.013 0.101 0.008
JNK 1 ph/tot 0.949 0.064 1.043 0.111 0.853 0.010
JNK 2/3 ph/tot 0.672 0.035 0.666 0.057 0.598 0.043
PKA C-a ph/tot 0.022 0.015 0.017 0.008 0.044 0.015
Pro-BDNF/GAPDH 0.372 0.050 0.517 0.048 0.284 0.081
Cortex
Akt ph/tot 0.782 0.011 0.734 0.024 0.732 0.025
Arc/GAPDH 0.577 0.050 0.648 0.010 0.598 0.028
Bcl-xL/GAPDH 0.536 0.081 0.680 0.077 0.693 0.042
BDNF/GAPDH 1.000 0.034 0.995 0.075 0.803 0.089
CNPase/GAPDH ratio 1.413 0.144 1.915 0.183 1.662 0.064
Erk1 ph/tot 0.955 0.177 0.731 0.043 0.845 0.041
Erk2 ph/tot 0.682 0.120 0.586 0.032 0.673 0.024
JNK 1 ph/tot 0.880 0.014 0.917 0.013 0.921 0.012
JNK 2/3 ph/tot 0.757 0.030 0.744 0.107 0.757 0.013
p38 ph/tot 0.732 0.077 0.903 0.002 0.593 0.086
Pro-BDNF/GAPDH 0.500 0.032 0.586 0.050 0.302 0.109
Statistical analysis (one-way ANOVA) was performed. Differences were all nonsignificant ( p> 0.05).
FIG. 9. Immunoblotting
analysis of proteins ex-
tracted from the cortex.
Crude cortical lysates (20–
40lg protein) were im-
munoblotted with antibodies
that specifically recognize
phospho-mTOR, total-mTOR,
phospho-CREB, and total
CREB. Results (phospho-/
total ratio for mTOR; protein/
GAPDH ratio for CREB) are
presented as means– SEM
(n‡ 3). a= p< 0.001 and c=
p < 0.05 represent significant
differences versus control
(one-way ANOVA).
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(1:1000), anti-total-JNK (1:1000), anti-Arc/Arg 3.1 C-7
(1:1000), anti-phospho-mTOR Ser2448 (1:1000), and anti-
mTOR (1:1000) fromNewEngland Biolabs; anti-phospho-PKA
C-a (1:1000), anti-total-PKA C-a (1:1000), anti CNPase
(1:1000), anti-dystrophin (1:500), and anti-Bcl-xL (1:500) from
Sigma. ECL reagent and hyperfilm-ECLwere purchased from
Amersham Biosciences. All other reagents were obtained
from Sigma or Merck.
Extraction and quantification of polyphenols
from Champagne wine
Champagne extracts were prepared using Champagne
wine derived from both Chardonnay and Pinot Noir and Pi-
not Meunier grapes as reported previously (65). Briefly,
375ml of Champagne was degassed, filtered, concentrated
under vacuum, and extracted with ethyl acetate. The organic
phase was separated from the aqueous phase and concen-
trated under reduced pressure to yield a brown aromatic
residue (yield = 1g/375ml). The obtained fraction was dis-
solved in methanol, filtered, and analyzed by HPLC. HPLC
analysis was carried out with an Agilent 1100 series liquid
chromatograph equipped with a diode array detector linked
to the HP ChemStation Software system. Samples were ana-
lyzed by reverse-phase HPLC using a NovaPak C18 column
(4.6 · 250mm, 4-lm particle size) fitted with a guard col-
umn C18 NovaPak from Waters. The temperature of the
column was maintained at 30C. The mobile phases consisted
of a mixture of aqueous methanol 5% in 0.1% hydrochloric
acid 5M (A) and amixture of aqueous acetonitrile 50% in 0.1%
hydrochloric acid 5 M (B) and were pumped through the
column at 0.7ml/min. The following gradient system was
used (min/% B): 0/5, 5/5, 40/50, 55/100, 59,9/100, and 60/5,
with 10-min postrun. The eluent was monitored by photodi-
ode array detection at 280 and 320 nm, and spectra of prod-
ucts were obtained over the 200–600-nm range. Calibration
curves of the phenolic compounds were constructed using
authentic standards (0.1–100mg/ml), and in each case were
found to be linear with correlation coefficients of .0.995. All
data were analyzed using ChemStation software.
Animals and supplementation. All procedures were fol-
lowed according to the specifications of the United Kingdom
Animals (Scientific Procedures) Act, 1986, and to the national
guidelines for the care and use of animals. Three groups of
adult, male Wistar rats (n = 8 per group; housed in cages each
containing 2 rats) were kept under controlled temperature
(22C– 1C) and humidity (50% – 10%), and on a 12:12 light–
dark cycle (lights off 10:00 h). All rats were 15 months old at
the beginning of the trial. Animals were pseudorandomly
assigned to 3 groups based on their baseline spatial working
memory correct-choice scores. Once allocated to a group,
animals were fed daily with Champagne, an isocaloric control
drink, or an isocaloric drink containing alcohol (Fig. 1D). The
isocaloric control was matched for macro- and micronutrient
content, notably glycerol, fructose, glucose, and citric acid
content, and was dissolved in carbonated water. The alcohol
control was similarly matched, but also contained alcohol
(12.5% vol). The Champagne wine used in the study also
contained phenolic compounds (gallic acid, protocatechuic
acid, tyrosol, caftaric acid, and caffeic acid). Champagne and
alcohol supplementation (1.78ml/kg bw) was approximately
equivalent to one 125-ml intake for a 70-Kg human and was
adjusted according to each animal’s body weight (approxi-
mate range 450–480 g). Alternatively, if we calculate the dose
according to the Human Equivalent Dose (HED) formula:
HED (mg/kg) = animal dose (mg/kg) * ([animal weight (kg)/
human weight (kg)]0.33 (40), the Champagne dose utilized in
our experiments is equivalent to 0.34mg kg- 1 day - 1 in hu-
mans (23.8mg Champagne in a 70-kg person per day). This
equates to a lower intake equivalent to 1.3 glasses of Cham-
pagne (125ml) per week in humans. To control daily intake of
the intervention diets, the three drinks were prepared freshly
each day and administered in the form of a mash, by mixing
the test solutions with a small amount (8 g/10ml) of pow-
dered standard diet (RM3; Special Diets Services), and the
correct amount given to each rat based on the bodyweight. At
the end of the spatial memory trials, animals were sacrificed
and the brains removed, the hippocampal and cortical regions
dissected, snap-frozen in liquid nitrogen, and stored at - 80C
until analysis.
Spatial working memory. Spatial working memory per-
formance was assessed using a cross-maze apparatus (36),
which is a commonly used paradigm to evaluate spatial
learning, working memory, and reference memory perfor-
mance in rodents (46, 69). All rats were fasted overnight be-
fore the procedure to provide sufficient motivation to ensure a
high level of response during testing. Extra maze cues (labo-
ratory furniture, lights, and several prominent visual features
on the walls) were held constant throughout the experiment.
Rats were given 2-week pretraining (habituation) that they
ran reliably from the start arm to locate the reward pellets in
both goal arms of the maze. This was followed by 6 weeks of
shaping sessions (each consisting of six trials) before initiation
of the supplementation regimes. During each shaping trial,
rats were trained to enter an open goal arm and collect a
reward pellet (entry to the alternate other goal arm was re-
stricted). Across each shaping session, the open goal arm
varied between trials according to a pseudorandom design.
After completion of the shaping sessions, dietary supple-
mentation and testing sessions were started. During the test-
ing phase, each animal received eight trials per test session,
with each consisting of a sample phase and a choice phase.
During the sample phase, rats were placed in the start arm
and allowed access only one goal arm to recover a food re-
ward. Once the reward pellet had been collected, animals
were removed and returned to the start arm for 10 s. During
the choice phase, both goal arms were accessible, and animals
were allowed a free choice between the two, with correct
choice responses recorded for animals entering arm not vis-
ited during the sample phase. An animal was deemed to have
selected an arm when it had placed a hind foot within the
confines of the arm correct arm (retracing was measured as a
failure on the task). Correct choices were rewarded with a
food reward, whereas incorrect arm choices meant the animal
was returned to its home cage. For 50% of the choice phases,
the rat was placed in the alternate start arm opposite to the
normal start arm. For each trial, accuracy and time taken to
make a choice were measured. The maze was cleaned with
50% ethanol solution between trials to remove any olfactory
clues. Each test session contained a pseudorandom sequence
of correct choices between the two arms, as well as a pseu-
dorandom sequence for the start arm during the choice phase.
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Rats were given 2 test sessions on the cross-maze, one session
administered immediately before supplementation (baseline)
and one administered at 6 weeks. Each group of aged animals
was pseudorandomly assigned before the intervention based
on the baseline correct-choice scores.
Stationary-beam test. The motor skills of the animals
during Champagne supplementation were tested on a sta-
tionary beam (55) at baseline and at the end of the intervention
(6 weeks). The dynamic equilibrium was tested on a beam
consisting of a scale (150 cm, 3-cm diameter) located 40 cm
above a soft carpet. At the beginning of the experiment, the rat
was placed on the middle of the beam, its body axis perpen-
dicular to the beam’s longitudinal axis. The distance covered
and latency times before falling were recorded, and the
walking speed was calculated. The trial was stopped when
the animal fell or 3min had elapsed.
Antibody array. The Panorama antibody array Cell Sig-
naling Kit (Sigma-Aldrich) was used, which contains 224
different antibodies spotted in duplicate on nitrocellulose
glass slides, and represents proteins involved in biological
pathways such as apoptosis, cell cycle, nuclear proteins,
neurobiology, cytoskeleton, and signal transduction. Three
biological replicates were used for the hippocampus region
and two biological replicates for the cortex region. Statistical
analysis was conducted on biological replicates, and signifi-
cantly modulated protein expression in the hippocampus and
in the cortex is reported in
ST1c
Supplementary Tables S1 andST2c S2
AU5c
,
respectively. Proteins from both the brain regions of the
Champagne-treated and control-treated animals were ex-
tracted, purified, labeled with Cy-fluorescent dyes, hybrid-
ized to microarrays (at concentration of 5lg/ml of each
labeled target), and washed according to the protocols pro-
vided by the manufacturer. Briefly, the protein extracts were
prepared using the extraction buffer provided in the kit, and
the protein concentration was determined in the supernatant
by the Bradford method. One mg of protein extract from each
sample was labeled with Cy5 or Cy3, according to the man-
ufacturer’s instructions. Free, nonincorporated Cy3 and Cy5
dyes were separated by applying the labeled extracts on the
SigmaSpin Post-Reaction Clean-Up Columns. The dye-to-
protein molar ratio (D/P) was calculated, and only samples
having D/P > 2 were used. An equal amount of labeled pro-
tein of both extracts (5lg/ml) was incubated on the micro-
array slide for 30min; all washes were done in PBS-Tween
0.05%. The microarray slides were scanned on a GenePix 4200
Professional scanner (Molecular Devices), with laser power
reduced to 25% and PMT settings manually adjusted to avoid
saturated pixels in the experimental spots, and the resulted
images were analyzed with GenePixPro 6 software (Mole-
cular Devices). Spot intensities were local background-
adjusted, and spots with negative values were removed from
further analysis. For the remaining spots, resulted intensities
were averaged for replicates, treatment-to-control ratios
calculated, log2-transformed, and normalized to median.
Western immunoblotting. The dissected brain regions
were homogenized on ice with a glass homogenizer using
CelLytic MT Cell Lysis Reagent (Sigma) containing cOm-
plete Mini protease inhibitors and PhosSTOP phosphatase
inhibitors. The homogenates were left on ice for 45min before
centrifugation at 4000 g for 5min at 4C to remove unbroken
cell debris and nuclei. The protein concentration in the su-
pernatants was determined by the Bradford protein assay.
Samples were incubated for 2min at 95C in boiling buffer
(final concentration 62.5mM Tris, pH 6.8, 2% SDS, 5% 2-
mercaptoethanol, 10% glycerol, and 0.0025% bromophenol
blue). Boiled samples (20–60lg/lane) and protein standards
were run on 9%–12% SDS–polyacrylamide gels, and proteins
were transferred to nitrocellulose membranes (Hybond-ECL;
Amersham) by semidry electroblotting (1.5mA/cm2). The
nitrocellulose membrane was then incubated in a blocking
buffer (20mM Tris, pH 7.5, 150mMNaCl; TBS) containing 4%
(w/v) skimmed milk powder for 45min at room temperature
followed by 2· 5-min washes in TBS supplemented with
0.05% (v/v) Tween 20 (TTBS). Blots were then incubated with
the primary antibodies of interest (1:200–1:2000 dilution) in
TTBS containing 1% (w/v) skimmed milk powder (antibody
buffer) overnight at 4C on a three-dimensional rocking table.
The blots were washed 2· 10min in TTBS and incubated with
secondary anti-rabbit or anti-mouse IgG conjugated to HRP
(1:1000 dilution) and Precision Protein StrepTactin–HRP
conjugate (1:10.000 dilution) for 45min. Finally, the blots were
washed 2 · 10min in TTBS rinsed in TBS and exposed to ECL
reagent for 1–2min and developed. The bands were analyzed
using Bio-Rad Quantity One 1-D Analysis software. Mole-
cular weights of the bands were calculated from comparison
with prestained molecular-weight markers that were run in
parallel with the samples. Relative band intensities were cal-
culated as a ratio of the phosphorylated protein to total pro-
tein in the case of CREB, p38, and mTOR. For BDNF,
dystrophin, CNPase, and Bcl-xL, the relative band intensity
was calculated in comparison to the GAPDH levels.
Statistics. All behavioral data (means – SEM, n = 8) were
subjected to two-way ANOVA for repeated measures with
the diet group (control, alcohol, and Champagne) and time (0
and 6 weeks) as main factors, followed by a Bonferroni
post hoc test to examine the differences between individual
treatments (GraphPad Prism 5). For the microarray data
(means – SEM, n= 4 for hippocampus, n = 4 for cortex), to
evaluate the difference in protein expression between the
Champagne-treated and isocaloric control-treated samples,
we used Rank Product Test (4), as implemented in MeV 4.6
microarray data analysis software (43), with a cutoff of log2-
ratio more than 0.4 or less than - 0.4 (more than 1.3-fold
change) and p < 0.05. For the western immunoblotting data
(means – SEM, n ‡ 3), the results were statistically evaluated
by one-way ANOVA, followed by a Student–Newman-Keuls
post hoc t-test (GraphPad Prism 5). Significant changes are
indicated as follows: a= p< 0.001; b = p< 0.01; c= p< 0.05.
Correlations between animal performance on spatial memory
tasks and protein levels in the brain were calculated using the
Pearson product moment correlation coefficient and the as-
sociated p value.
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Akt¼Akt/Protein kinase B
ANOVA¼ analysis of variance
Arc¼ activity-regulated cytoskeleton-associated
protein
ATF2¼ activating transcription factor 2
BBB¼ blood–brain barrier
Bcl-x¼B-cell lymphoma 2-associated x protein
Bcl-xL¼B-cell lymphoma 2 extra-large protein
BDNF¼ brain-derived neurotrophic factor
Cdc27¼ cell division cycle protein 27
c-myc¼Myc proto-oncogene protein
CNPase¼ 2¢,3¢-cyclic-nucleotide 3¢-phosphodiesterase
CREB¼ cAMP response-element-binding protein
E2F1¼ transcription factor E2F1
Erk¼ extracellular-signal-regulated kinase
FAK¼ focal adhesion kinase
GADD 153¼ growth arrest and DNA damage-inducible
protein 153
GRB2¼ growth factor receptor-bound protein 2
HPLC¼high performance liquid chromatography
JNK¼ c-Jun aminoterminal Kinases
MAPK¼mitogen-activated protein kinase
MPTP¼ 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
mTOR¼mammalian target of rapamycin
NGFR p75¼p75 Nerve Growth Factor Receptor, low
affinity
NMDAR 2a¼N-methyl-d-aspartate receptor 2a
NO¼nitric oxide
p38¼mitogen-activated protein kinase 14
(p38-alpha)
p57kip2¼ cyclin-dependent kinase inhibitor 1C,
p57 isoform 1
PCAF¼P300/CBP-associated factor
PGE2¼Prostaglandin E2
PKA C-a¼ cAMP-dependent protein kinase catalytic
subunit-alpha
PKC a¼Protein kinase C-alpha
PKC b¼Protein kinase C-beta
PKC g¼Protein kinase C-gamma
pro-BDNF¼ brain-derived neurotrophic factor precursor
PSR¼phosphatidylserine receptor
PTEN¼phosphatase and tensin homolog
Pyk2¼protein tyrosine kinase 2
raf-1¼RAF proto-oncogene serine/threonine-
protein kinase
STRING¼ Search Tool for the Retrieval of Interacting
Genes/Proteins
Tau¼microtubule-associated protein tau
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